Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MP Materials Corp. / DEMP · Entity 3549 | Director | December 13, 2022 | December 15, 2022 |
| Okeanis Eco Tankers Corp.ECO · Entity 4305 | Director | August 13, 2026 | August 17, 2026 |
| Roivant Sciences Ltd.ROIV · Entity 3185 | Director | September 16, 2026 | September 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MP Materials Corp. / DE
Report date December 13, 2022 · Filed December 15, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Fourth Avenue FF Opportunities LP - Series E | 6,839,564 |
Last balance in matching sequence
After 2022-12-14 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2022-12-13 · Sale · Disposed 25,329 · Balance 6,892,097 F1: Management of Fourth Avenue FF-E is vested in its general partner, Fourth Avenue Capital Partners GP LLC, a Delaware limited liability company ("Fourth Avenue GP"), which may be deemed to beneficially own the shares of MP Materials Corp. (the "Issuer") Class A common stock ("Shares") held directly by Fourth Avenue FF-E. Daniel Gold is a Managing Member of Fourth Avenue GP, sharing voting and investment control over the Shares held directly by Fourth Avenue FF-E and may be deemed to beneficially own such Shares. F2: Daniel Gold disclaims any beneficial ownership in the Shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Row 4 · 2022-12-13 · Sale · Disposed 25,329 · Balance 6,866,768 F1: Management of Fourth Avenue FF-E is vested in its general partner, Fourth Avenue Capital Partners GP LLC, a Delaware limited liability company ("Fourth Avenue GP"), which may be deemed to beneficially own the shares of MP Materials Corp. (the "Issuer") Class A common stock ("Shares") held directly by Fourth Avenue FF-E. Daniel Gold is a Managing Member of Fourth Avenue GP, sharing voting and investment control over the Shares held directly by Fourth Avenue FF-E and may be deemed to beneficially own such Shares. F2: Daniel Gold disclaims any beneficial ownership in the Shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Row 7 · 2022-12-14 · Sale · Disposed 27,204 · Balance 6,839,564 F1: Management of Fourth Avenue FF-E is vested in its general partner, Fourth Avenue Capital Partners GP LLC, a Delaware limited liability company ("Fourth Avenue GP"), which may be deemed to beneficially own the shares of MP Materials Corp. (the "Issuer") Class A common stock ("Shares") held directly by Fourth Avenue FF-E. Daniel Gold is a Managing Member of Fourth Avenue GP, sharing voting and investment control over the Shares held directly by Fourth Avenue FF-E and may be deemed to beneficially own such Shares. F2: Daniel Gold disclaims any beneficial ownership in the Shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by QVT Family Office Onshore LP | 1,120,014 |
Last balance in matching sequence
After 2022-12-14 transaction · row 8
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 2 · 2022-12-13 · Sale · Disposed 4,148 · Balance 1,128,617 F2: Daniel Gold disclaims any beneficial ownership in the Shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly. F3: Management of QVT Family Office Onshore LP ("QVT Onshore") is vested in its general partner, QVT Associates GP LLC, a Delaware limited liability company ("QVT Associates GP"), which may be deemed to beneficially own the Shares held directly by QVT Onshore. QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Onshore and Saratoga Park Ltd. ("Saratoga"), and shares voting and investment control over the Shares held directly by QVT Onshore and Saratoga. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. Daniel Gold is a Managing Member of each of QVT Associates GP and QVT Financial GP, sharing voting and investment control over the Shares held directly by QVT Onshore and Saratoga and may be deemed to beneficially own such Shares. Row 5 · 2022-12-13 · Sale · Disposed 4,148 · Balance 1,124,469 F2: Daniel Gold disclaims any beneficial ownership in the Shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly. F3: Management of QVT Family Office Onshore LP ("QVT Onshore") is vested in its general partner, QVT Associates GP LLC, a Delaware limited liability company ("QVT Associates GP"), which may be deemed to beneficially own the Shares held directly by QVT Onshore. QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Onshore and Saratoga Park Ltd. ("Saratoga"), and shares voting and investment control over the Shares held directly by QVT Onshore and Saratoga. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. Daniel Gold is a Managing Member of each of QVT Associates GP and QVT Financial GP, sharing voting and investment control over the Shares held directly by QVT Onshore and Saratoga and may be deemed to beneficially own such Shares. Row 8 · 2022-12-14 · Sale · Disposed 4,455 · Balance 1,120,014 F2: Daniel Gold disclaims any beneficial ownership in the Shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly. F3: Management of QVT Family Office Onshore LP ("QVT Onshore") is vested in its general partner, QVT Associates GP LLC, a Delaware limited liability company ("QVT Associates GP"), which may be deemed to beneficially own the Shares held directly by QVT Onshore. QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Onshore and Saratoga Park Ltd. ("Saratoga"), and shares voting and investment control over the Shares held directly by QVT Onshore and Saratoga. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. Daniel Gold is a Managing Member of each of QVT Associates GP and QVT Financial GP, sharing voting and investment control over the Shares held directly by QVT Onshore and Saratoga and may be deemed to beneficially own such Shares. |
| Class A Common SockSEC Table I · non-derivative | IndirectHeld by Saratoga Park Ltd. | 5,584,566 |
Reported balance
After 2022-12-13 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2022-12-13 · Sale · Disposed 20,523 · Balance 5,584,566 F2: Daniel Gold disclaims any beneficial ownership in the Shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly. F3: Management of QVT Family Office Onshore LP ("QVT Onshore") is vested in its general partner, QVT Associates GP LLC, a Delaware limited liability company ("QVT Associates GP"), which may be deemed to beneficially own the Shares held directly by QVT Onshore. QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Onshore and Saratoga Park Ltd. ("Saratoga"), and shares voting and investment control over the Shares held directly by QVT Onshore and Saratoga. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. Daniel Gold is a Managing Member of each of QVT Associates GP and QVT Financial GP, sharing voting and investment control over the Shares held directly by QVT Onshore and Saratoga and may be deemed to beneficially own such Shares. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Saratoga Park Ltd. | 5,542,000 |
Last balance in matching sequence
After 2022-12-14 transaction · row 9
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 6 · 2022-12-13 · Sale · Disposed 20,523 · Balance 5,564,043 F2: Daniel Gold disclaims any beneficial ownership in the Shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly. F3: Management of QVT Family Office Onshore LP ("QVT Onshore") is vested in its general partner, QVT Associates GP LLC, a Delaware limited liability company ("QVT Associates GP"), which may be deemed to beneficially own the Shares held directly by QVT Onshore. QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Onshore and Saratoga Park Ltd. ("Saratoga"), and shares voting and investment control over the Shares held directly by QVT Onshore and Saratoga. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. Daniel Gold is a Managing Member of each of QVT Associates GP and QVT Financial GP, sharing voting and investment control over the Shares held directly by QVT Onshore and Saratoga and may be deemed to beneficially own such Shares. Row 9 · 2022-12-14 · Sale · Disposed 22,043 · Balance 5,542,000 F2: Daniel Gold disclaims any beneficial ownership in the Shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly. F3: Management of QVT Family Office Onshore LP ("QVT Onshore") is vested in its general partner, QVT Associates GP LLC, a Delaware limited liability company ("QVT Associates GP"), which may be deemed to beneficially own the Shares held directly by QVT Onshore. QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Onshore and Saratoga Park Ltd. ("Saratoga"), and shares voting and investment control over the Shares held directly by QVT Onshore and Saratoga. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. Daniel Gold is a Managing Member of each of QVT Associates GP and QVT Financial GP, sharing voting and investment control over the Shares held directly by QVT Onshore and Saratoga and may be deemed to beneficially own such Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Management of Fourth Avenue FF-E is vested in its general partner, Fourth Avenue Capital Partners GP LLC, a Delaware limited liability company ("Fourth Avenue GP"), which may be deemed to beneficially own the shares of MP Materials Corp. (the "Issuer") Class A common stock ("Shares") held directly by Fourth Avenue FF-E. Daniel Gold is a Managing Member of Fourth Avenue GP, sharing voting and investment control over the Shares held directly by Fourth Avenue FF-E and may be deemed to beneficially own such Shares.
F2: Daniel Gold disclaims any beneficial ownership in the Shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
F3: Management of QVT Family Office Onshore LP ("QVT Onshore") is vested in its general partner, QVT Associates GP LLC, a Delaware limited liability company ("QVT Associates GP"), which may be deemed to beneficially own the Shares held directly by QVT Onshore. QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Onshore and Saratoga Park Ltd. ("Saratoga"), and shares voting and investment control over the Shares held directly by QVT Onshore and Saratoga. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. Daniel Gold is a Managing Member of each of QVT Associates GP and QVT Financial GP, sharing voting and investment control over the Shares held directly by QVT Onshore and Saratoga and may be deemed to beneficially own such Shares.
Okeanis Eco Tankers Corp.
Report date August 13, 2026 · Filed August 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | IndirectHeld by QVT Family Office Fund LP | 1,347,038 |
Last balance in matching sequence
After 2026-08-14 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-08-13 · Sale · Disposed 8,539 · Balance 1,415,458 F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Row 2 · 2026-08-14 · Sale · Disposed 68,420 · Balance 1,347,038 F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
Roivant Sciences Ltd.
Report date September 16, 2026 · Filed September 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 8,965,815 |
Reported balance
After 2026-09-16 transaction · row 1
1 source rowRow 1 · 2026-09-16 · Grant · Acquired 5,054 · Balance 8,965,815 F1: Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.57 · Expires 2036-09-15 | Direct | 10,531 |
Reported balance
After 2026-09-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-16 · Grant · Acquired 10,531 · Balance 10,531 F2: Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
F2: Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2026 Filed Sep 18, 2026 23:12 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantStock Option (Right to Buy) · Derivative | 10,531 | $0.00 Strike: $39.57 | $0.00 |
DisclosureSEC source: 0001635088-26-000102 · wk-form4_1789773168.xml · derivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,531 Underlying: Common Shares · 10,531 shares Expires 2036-09-15 F2 · derivative.exercise_date: Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 23:12 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantCommon Shares | 5,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001635088-26-000102 · wk-form4_1789773168.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,965,815 F1 · shares: Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date. F1 · price: Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date. Read SEC document |
| September 10, 2026 Filed Sep 15, 2026 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | Tax withholdingCommon Shares | 5,133 | $40.94 | $210,145.02 |
DisclosureSEC source: 0001140361-26-036535 · form4.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,960,761 F1 · shares: Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 22:01 UTC | Okeanis Eco Tankers Corp. ECO · Entity 4305 | SaleCommon Shares | 68,420 | $59.99 | $4,104,515.80 |
DisclosureSEC source: 0001193125-26-354362 · ownership.xml · nonDerivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Family Office Fund LP Disclosed balance after: 1,347,038 F1 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 22:01 UTC | Okeanis Eco Tankers Corp. ECO · Entity 4305 | SaleCommon Shares | 8,539 | $65.04 | $555,376.56 |
DisclosureSEC source: 0001193125-26-354362 · ownership.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Family Office Fund LP Disclosed balance after: 1,415,458 F1 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 00:30 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 12,380 | $35.28 | $436,766.40 |
DisclosureSEC source: 0001193125-26-291163 · ownership.xml · nonDerivative · entry 5 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 13,689,166 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 00:30 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 600,000 | $34.59 | $20,754,000.00 |
DisclosureSEC source: 0001193125-26-291163 · ownership.xml · nonDerivative · entry 4 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 13,701,546 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 00:30 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 200,000 | $34.44 | $6,888,000.00 |
DisclosureSEC source: 0001193125-26-291163 · ownership.xml · nonDerivative · entry 3 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 14,301,546 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| June 26, 2026 Filed Jul 1, 2026 00:30 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 325,000 | $34.07 | $11,072,750.00 |
DisclosureSEC source: 0001193125-26-291163 · ownership.xml · nonDerivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 14,501,546 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| June 26, 2026 Filed Jul 1, 2026 00:30 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 300,783 | $33.92 | $10,202,559.36 |
DisclosureSEC source: 0001193125-26-291163 · ownership.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 14,826,546 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 13, 2026 Filed Feb 14, 2026 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 225,000 | $26.50 | $5,962,500.00 |
DisclosureSEC source: 0001193125-26-052128 · ownership.xml · nonDerivative · entry 5 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 15,127,329 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 13, 2026 Filed Feb 14, 2026 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 150,784 | $26.49 | $3,994,268.16 |
DisclosureSEC source: 0001193125-26-052128 · ownership.xml · nonDerivative · entry 4 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 15,352,329 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 12, 2026 Filed Feb 14, 2026 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 275,000 | $26.76 | $7,359,000.00 |
DisclosureSEC source: 0001193125-26-052128 · ownership.xml · nonDerivative · entry 3 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 15,503,113 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 12, 2026 Filed Feb 14, 2026 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 150,000 | $26.72 | $4,008,000.00 |
DisclosureSEC source: 0001193125-26-052128 · ownership.xml · nonDerivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 15,778,113 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 11, 2026 Filed Feb 14, 2026 02:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 425,000 | $26.67 | $11,334,750.00 |
DisclosureSEC source: 0001193125-26-052128 · ownership.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 15,928,113 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 00:54 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 189,538 | $23.17 | $4,391,595.46 |
DisclosureSEC source: 0001193125-25-325359 · ownership.xml · nonDerivative · entry 5 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 16,353,113 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 00:54 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 155,076 | $23.02 | $3,569,849.52 |
DisclosureSEC source: 0001193125-25-325359 · ownership.xml · nonDerivative · entry 4 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 16,542,651 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 00:54 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 432,718 | $23.05 | $9,974,149.90 |
DisclosureSEC source: 0001193125-25-325359 · ownership.xml · nonDerivative · entry 3 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 16,697,727 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 00:54 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 642,282 | $23.08 | $14,823,868.56 |
DisclosureSEC source: 0001193125-25-325359 · ownership.xml · nonDerivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 17,130,445 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 00:54 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 275,000 | $22.93 | $6,305,750.00 |
DisclosureSEC source: 0001193125-25-325359 · ownership.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 17,772,727 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 19, 2025 Filed Nov 22, 2025 01:22 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 175,000 | $20.24 | $3,542,000.00 |
DisclosureSEC source: 0001193125-25-291731 · ownership.xml · nonDerivative · entry 4 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 18,047,727 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 19, 2025 Filed Nov 22, 2025 01:22 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 125,000 | $20.16 | $2,520,000.00 |
DisclosureSEC source: 0001193125-25-291731 · ownership.xml · nonDerivative · entry 3 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 18,222,727 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 19, 2025 Filed Nov 22, 2025 01:22 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 150,000 | $20.20 | $3,030,000.00 |
DisclosureSEC source: 0001193125-25-291731 · ownership.xml · nonDerivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 18,347,727 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 19, 2025 Filed Nov 22, 2025 01:22 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 850,000 | $20.25 | $17,212,500.00 |
DisclosureSEC source: 0001193125-25-291731 · ownership.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 18,497,727 F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 10, 2025 Filed Sep 13, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantStock Option (Right to Buy) · Derivative | 33,726 | $0.00 Strike: $13.77 | $0.00 |
DisclosureSEC source: 0001140361-25-034933 · form4.xml · derivative · entry 3 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,726 Underlying: Common Shares · 33,726 shares Expires 2035-09-09 F3 · derivative.exercise_date: Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date. Read SEC document |
| September 10, 2025 Filed Sep 13, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 5,270 | $13.77 | $72,567.90 |
DisclosureSEC source: 0001140361-25-034933 · form4.xml · nonDerivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,965,894 F2 · shares: Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares. Read SEC document |
| September 10, 2025 Filed Sep 13, 2025 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantCommon Shares | 14,524 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-034933 · form4.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,971,164 F1 · shares: Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date. F1 · price: Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 3,176,245 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-090997 · ownership.xml · nonDerivative · entry 6 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 19,347,727 F1 · kind: On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd. contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F6 · ownership.nature: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 6,205,368 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-090997 · ownership.xml · nonDerivative · entry 5 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Deferred Compensation Holdings Ltd. Disclosed balance after: 8,441,428 F1 · kind: On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd. contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F5 · ownership.nature: The reporting person is one of two directors of QVT P&E Roiv Hldgs Ltd. ("QVT P&E") and QVT Deferred Compensation Holdings Ltd ("QVT DCH"), sharing voting and investment control over the Common Shares held directly by QVT P&E and QVT DCH. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 1,170,646 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-090997 · ownership.xml · nonDerivative · entry 4 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT P&E Roiv Hldgs Ltd. Disclosed balance after: 1,592,480 F1 · kind: On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd. contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F5 · ownership.nature: The reporting person is one of two directors of QVT P&E Roiv Hldgs Ltd. ("QVT P&E") and QVT Deferred Compensation Holdings Ltd ("QVT DCH"), sharing voting and investment control over the Common Shares held directly by QVT P&E and QVT DCH. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 55,443 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-090997 · ownership.xml · nonDerivative · entry 3 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Fourth Avenue Capital Partners LP Disclosed balance after: 0 F1 · kind: On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd. contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F4 · ownership.nature: Management of Fourth Avenue is vested in its general partner, Fourth Avenue Capital Partners GP LLC, a Delaware limited liability company ("Fourth Avenue GP"), which may be deemed to beneficially own the Common Shares held directly by Fourth Avenue. Daniel Gold is a Managing Member of Fourth Avenue GP, sharing voting and investment control over the Common Shares held directly by Fourth Avenue and may be deemed to beneficially own such Common Shares. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 6,837,266 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-090997 · ownership.xml · nonDerivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Roiv Hldgs Onshore Ltd. Disclosed balance after: 0 F1 · kind: On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd. contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Roiv, and shares voting and investment control over the Shares held directly by QVT Roiv. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. The reporting person is a Managing Member of QVT Financial GP, sharing voting and investment control over the Common Shares held directly by QVT Roiv and may be deemed to beneficially own such Common Shares. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 19,311,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-090997 · ownership.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Roiv Hldgs Offshore Ltd. Disclosed balance after: 0 F1 · kind: On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd. contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Roiv, and shares voting and investment control over the Shares held directly by QVT Roiv. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. The reporting person is a Managing Member of QVT Financial GP, sharing voting and investment control over the Common Shares held directly by QVT Roiv and may be deemed to beneficially own such Common Shares. Read SEC document |
| September 26, 2024 Filed Sep 27, 2024 00:34 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 876,000 | $11.82 | $10,354,320.00 |
DisclosureSEC source: 0000950170-24-109731 · ownership.xml · nonDerivative · entry 6 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 22,179,358 F2 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F2 · ownership.nature: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 00:34 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 50,000 | $11.77 | $588,500.00 |
DisclosureSEC source: 0000950170-24-109731 · ownership.xml · nonDerivative · entry 5 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 23,055,358 F2 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F2 · ownership.nature: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 00:34 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 365,551 | $11.77 | $4,300,817.18 |
DisclosureSEC source: 0000950170-24-109731 · ownership.xml · nonDerivative · entry 4 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trusts and estate planning vehicles established by the Reporting Person Disclosed balance after: 1,713,508 F1 · ownership.direct: The reporting person is a trustee of trusts and estate planning vehicles, each of which were formed by the reporting person and/or his immediate family members, and shares voting and investment control over the Common Shares held directly by these trusts and may be deemed to beneficially own such Common Shares. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 00:34 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 991,593 | $11.77 | $11,666,389.12 |
DisclosureSEC source: 0000950170-24-109731 · ownership.xml · nonDerivative · entry 3 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,731,830 Read SEC document |
| September 24, 2024 Filed Sep 27, 2024 00:34 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 577,186 | $11.63 | $6,709,787.25 |
DisclosureSEC source: 0000950170-24-109731 · ownership.xml · nonDerivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trusts and estate planning vehicles established by the Reporting Person Disclosed balance after: 2,079,059 F1 · ownership.direct: The reporting person is a trustee of trusts and estate planning vehicles, each of which were formed by the reporting person and/or his immediate family members, and shares voting and investment control over the Common Shares held directly by these trusts and may be deemed to beneficially own such Common Shares. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 24, 2024 Filed Sep 27, 2024 00:34 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 1,565,670 | $11.63 | $18,200,913.75 |
DisclosureSEC source: 0000950170-24-109731 · ownership.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,723,423 Read SEC document |
| September 12, 2024 Filed Sep 17, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 2,599 | $12.12 | $31,499.88 |
DisclosureSEC source: 0001140361-24-041231 · form4.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,289,093 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| September 10, 2024 Filed Sep 13, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantStock Option (Right to Buy) · Derivative | 27,894 | $0.00 Strike: $12.19 | $0.00 |
DisclosureSEC source: 0001140361-24-040989 · form4.xml · derivative · entry 3 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,894 Underlying: Common Shares · 27,894 shares Expires 2034-09-09 F3 · derivative.exercise_date: Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date. Read SEC document |
| September 10, 2024 Filed Sep 13, 2024 01:00 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | GrantCommon Shares | 16,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-040989 · form4.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,291,692 F1 · shares: Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date. F1 · price: Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 23:09 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 11,325,233 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-028201 · ownership.xml · nonDerivative · entry 6 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd Disclosed balance after: 23,105,358 F1 · kind: On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F6 · ownership.nature: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 23:09 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 11,077,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-028201 · ownership.xml · nonDerivative · entry 5 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Deferred Compensation Holdings Ltd Disclosed balance after: 14,646,796 F1 · kind: On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F5 · ownership.nature: The reporting person is one of two directors of QVT P&E Roiv Hldgs Ltd. ("QVT P&E") and QVT Deferred Compensation Holdings Ltd ("QVT DCH"), sharing voting and investment control over the Common Shares held directly by QVT P&E and QVT DCH. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 23:09 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 2,260,661 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-028201 · ownership.xml · nonDerivative · entry 4 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT P&E Roiv Hldgs Ltd Disclosed balance after: 2,763,126 F1 · kind: On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F5 · ownership.nature: The reporting person is one of two directors of QVT P&E Roiv Hldgs Ltd. ("QVT P&E") and QVT Deferred Compensation Holdings Ltd ("QVT DCH"), sharing voting and investment control over the Common Shares held directly by QVT P&E and QVT DCH. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 23:09 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 45,361 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-028201 · ownership.xml · nonDerivative · entry 3 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Fourth Avenue Capital Partners LP Disclosed balance after: 55,443 F1 · kind: On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F4 · ownership.nature: Management of Fourth Avenue is vested in its general partner, Fourth Avenue Capital Partners GP LLC, a Delaware limited liability company ("Fourth Avenue GP"), which may be deemed to beneficially own the Common Shares held directly by Fourth Avenue. Daniel Gold is a Managing Member of Fourth Avenue GP, sharing voting and investment control over the Common Shares held directly by Fourth Avenue and may be deemed to beneficially own such Common Shares. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 23:09 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 5,594,064 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-028201 · ownership.xml · nonDerivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Roiv Hldgs Onshore Ltd Disclosed balance after: 6,837,266 F1 · kind: On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Roiv, and shares voting and investment control over the Shares held directly by QVT Roiv. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. The reporting person is a Managing Member of QVT Financial GP, sharing voting and investment control over the Common Shares held directly by QVT Roiv and may be deemed to beneficially own such Common Shares. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 23:09 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | OtherCommon Shares | 15,518,673 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-028201 · ownership.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Roiv Hldgs Offshore Ltd Disclosed balance after: 19,311,790 F1 · kind: On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Roiv, and shares voting and investment control over the Shares held directly by QVT Roiv. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. The reporting person is a Managing Member of QVT Financial GP, sharing voting and investment control over the Common Shares held directly by QVT Roiv and may be deemed to beneficially own such Common Shares. Read SEC document |
| September 28, 2023 Filed Oct 3, 2023 00:55 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 446,394 | $11.55 | $5,155,850.70 |
DisclosureSEC source: 0000899243-23-019661 · doc4.xml · nonDerivative · entry 6 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT P&E Roiv Hldgs Ltd Disclosed balance after: 5,023,787 F1 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F4 · ownership.nature: The reporting person is one of two directors of QVT P&E Roiv Hldgs Ltd. ("QVT P&E") and QVT Deferred Compensation Holdings Ltd ("QVT DCH"), sharing voting and investment control over the Common Shares held directly by QVT P&E and QVT DCH. Read SEC document |
| September 28, 2023 Filed Oct 3, 2023 00:55 UTC | Roivant Sciences Ltd. ROIV · Entity 3185 | SaleCommon Shares | 1,104,599 | $11.55 | $12,758,118.45 |
DisclosureSEC source: 0000899243-23-019661 · doc4.xml · nonDerivative · entry 5 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by QVT Roiv Hldgs Onshore Ltd Disclosed balance after: 12,431,330 F1 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), and shares voting and investment control over the Shares held directly by QVT Roiv. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. The reporting person is a Managing Member of QVT Financial GP, sharing voting and investment control over the Common Shares held directly by QVT Roiv and may be deemed to beneficially own such Common Shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.